Separatome-based protein expression and purification platform

US9816068B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9816068-B2
Application numberUS-201414521845-A
CountryUS
Kind codeB2
Filing dateOct 23, 2014
Priority dateMar 13, 2012
Publication dateNov 14, 2017
Grant dateNov 14, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a separatome-based recombinant peptide, polypeptide, and protein expression and purification platform based on the juxtaposition of the binding properties of host cell genomic peptides, polypeptides, and proteins with the characteristics and location of the corresponding genes on the host cell chromosome, such as that of E. coli , yeast, Bacillus subtilis or other prokaryotes, insect cells, mammalian cells, etc. This platform quantitatively describes and identifies priority deletions, modifications, or inhibitions of certain gene products to increase chromatographic separation efficiency, defined as an increase in column capacity, column selectivity, or both, with emphasis on the former. Moreover, the platform provides a computerized knowledge tool that, given separatome data and a target recombinant peptide, polypeptide, or protein, intuitively suggests strategies leading to efficient product purification. The separatome-based protein expression and purification platform is an efficient bioseparation system that intertwines host cell expression systems and chromatography.

First claim

Opening claim text (preview).

What is claimed is: 1. An isolated host cell for expression of a target recombinant peptide, polypeptide, or protein, wherein the chromatographic separation efficiency of said target recombinant peptide, polypeptide, or protein expressed in said host cell is improved in an amount in the range of from about 5% to about 35%, wherein the genome of said host cell: a) is a reduced genome, b) a modified genome, or c) a genome in which expression of genes is reduced or completely inhibited, wherein genes that are deleted, modified, or the expression of which is reduced or completely inhibited in said host cell code for peptides, polypeptides, or proteins that impair the chromatographic separation efficiency of said target recombinant peptide, polypeptide, or protein expressed in said host cell, wherein deletion, modification, reduction of expression, or complete inhibition of expression of said genes in said host cell improves the chromatographic separation efficiency of said target recombinant peptide, polypeptide, or protein expressed in said host cell in an amount in the range of from about 5% to about 35% compared to the chromatographic separation efficiency of said target recombinant peptide, polypeptide, or protein expressed in said host cell when said genes are not deleted, not modified, or the expression of which is not reduced or completely inhibited in said host cell, respectively, and wherein genes that are deleted, modified, or the expression of which is reduced or completely inhibited, in the genome of said host cell are identified and ranked according to chromatographic relevance in adversely affecting said chromatographic separation efficiency of said target recombinant peptide, polypeptide, or protein by: i) equilibrating an affinity chromatography column comprising an affinity ligand bound to a solid phase, or an adsorption-based, non-affinity chromatography column comprising an adsorption-based, non-affinity chromatography medium, using a mobile loading or eluting phase, or an operational variable; ii) in the case where said target recombinant peptide, polypeptide, or protein is not secreted, fractionating a lysate of said host cell, or in the case where said target recombinant peptide, polypeptide, or protein is secreted from said host cell, fractionating the culture medium in which said host cell is grown, on either of said columns by applying an elution gradient to elute peptide, polypeptide, or protein fractions from said column; iii) identifying, quantifying, and scoring peptides, polypeptides, or proteins in fractions eluted from either of said columns; iv) assessing the metabolic role of said peptides, polypeptides, or proteins identified in step iii) that affect column capacity; and v) reducing or modifying the genome of said host cell, or reducing or completely inhibiting expression of genes in said host cell, thereby modifying the proteome of said host cell and increasing chromatographic separation efficiency of said target recombinant peptide, polypeptide, or protein, based on steps iii) and iv) in an amount in the range of from about 5% to about 35% compared to the chromatographic separation efficiency of said target recombinant peptide, polypeptide, or protein expressed in said host cell when said genes are not deleted, not modified, or the expression of which is not inhibited in said host cell, respectively, wherein host cell peptides, polypeptides, and proteins are scored, and ranked in order of importance, in step iii) according to the following equation: importance i = ∑ j ⁢ ⁢ [ b 1 ⁡ ( y c j y max ) ⁢ ( h i ⁢ , j h i , total ) ⁢ ( h i ⁢ , j h j , total ) ⁢ ( M ⁢ ⁢ W i M ⁢ ⁢ W ref ) α ] i wherein b 1 =scaling parameter; y cj and y max =concentration of mobile phase eluent in fraction (j) and maximum value, respectively; h i,j and h i, total =the amount of protein (i) in fraction (j) and total bound protein (i), respectively; h j,total =total amount of protein in fraction (j); MW i =molecular weight of protein (i); MW ref =molecular weight of a reference protein within the separatome; α=steric factor; and i=protein, wherein: ratio

Assignees

Inventors

Classifications

  • Equilibration or regeneration · CPC title

  • Vectors or expression systems specially adapted for eukaryotic hosts · CPC title

  • Elution mode · CPC title

  • Anion-exchange · CPC title

  • C12N1/20Primary

    Bacteria; Culture media therefor · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9816068B2 cover?
Provided is a separatome-based recombinant peptide, polypeptide, and protein expression and purification platform based on the juxtaposition of the binding properties of host cell genomic peptides, polypeptides, and proteins with the characteristics and location of the corresponding genes on the host cell chromosome, such as that of E. coli , yeast, Bacillus subtilis or other prokaryotes, in…
Who is the assignee on this patent?
Univ Arkansas, Univ Of Pittsburgh-Of The Commonwealth System Of Higher Education, Univ Arkansas, and 1 more
What technology area does this patent fall under?
Primary CPC classification C12N1/20. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).